Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06742021 | Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer | recruiting | N/A | 195 | Yunnan Cancer HospitalOTHER | 1 | Dec 19, 2024 | clinicaltrials |
| NCT06705465 | Cross-sectorial Rehabilitation of Patients with Lung Cancer | recruiting | N/A | 130 | Camilla BalleOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06252233 |
| Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer(LePaLuMo) |
| recruiting |
| N/A |
| 220 |
| University of BayreuthOTHER |
| 1 |
| Dec 16, 2024 |
| clinicaltrials |
| NCT05349227 | Comprehensive Outcomes for After Cancer Health(COACH) | recruiting | N/A | 625 | Pack HealthINDUSTRY | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06423690 | First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System | recruiting | N/A | 15 | Snipe MedicalINDUSTRY | 3 | Dec 10, 2024 | clinicaltrials |
| NCT04605146 | Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy(MONITOR) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06632886 | AI-Assisted Non-Contrast CT for Multi-Cancer Screening | recruiting | N/A | 1,000,000 | Guo ShiWeiOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06628102 | Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study(IDEAL) | recruiting | N/A | 3,600 | British Columbia Cancer AgencyOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT06626178 | Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.(ARIA) | recruiting | N/A | 2,840 | Scientific Institute San RaffaeleOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT05557552 | Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer | recruiting | N/A | 56 | Ruijin HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06598839 | Immuno-effect of Tα1 for Stage I NSCLC | recruiting | N/A | 40 | Yousheng MaoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06354959 | Prehab for Lung and Esophageal Cancer | recruiting | N/A | 25 | Nova Scotia Health AuthorityOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06428422 | The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients | recruiting | N/A | 100 | Necmettin Erbakan UniversityOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT06531460 | Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection | recruiting | N/A | 310 | National Institute of Respiratory Diseases, MexicoOTHER_GOV | 1 | Aug 1, 2024 | clinicaltrials |
| NCT06244264 | The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis | recruiting | N/A | 118 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT06476093 | SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer | recruiting | N/A | 46 | The First People's Hospital of LianyungangOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT03769129 | Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC | recruiting | N/A | 100 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06404164 | Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection | recruiting | N/A | 3,000 | Guangdong Provincial People's HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06387017 | Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway(BIOCEPTION) | recruiting | N/A | 750 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT05704920 | Integrating Artificial Intelligence Into Lung Cancer Screening.(DACAPO) | recruiting | N/A | 2,722 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06360627 | Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT | recruiting | N/A | 100 | University of ZurichOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06020430 | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | recruiting | N/A | 134 | Hubei Cancer HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06037733 | Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy | recruiting | N/A | 134 | Hubei Cancer HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06053099 | A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)(ROSIE) | recruiting | N/A | 300 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06286150 | Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery | recruiting | N/A | 20 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06262386 | Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial | recruiting | N/A | 358 | Chang Gung Memorial HospitalOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT04938804 | Non-risk Based Lang Cancer Screening With a One-off LDCT | recruiting | N/A | 11,000 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06188650 | The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study | recruiting | N/A | 30 | Ningbo Medical Center Lihuili HospitalOTHER_GOV | 1 | Jan 3, 2024 | clinicaltrials |
| NCT05689619 | SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)(SILMET) | recruiting | N/A | 70 | A.O.U. Città della Salute e della ScienzaOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT06168032 | COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research | recruiting | N/A | 1,224 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06052098 | Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer | recruiting | N/A | 110 | Hangzhou Broncus Medical Co., Ltd.INDUSTRY | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04790253 | PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)(PRIMALung) | recruiting | N/A | 600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Nov 3, 2023 | clinicaltrials |
| NCT05724004 | Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)(A-SAB) | recruiting | N/A | 70 | Karolinska University HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04631770 | Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC | recruiting | N/A | 1,362 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06056115 | Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic | recruiting | N/A | 20 | Hebei Medical University Fourth HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03742687 | Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | recruiting | N/A | 151 | Danish Lung Cancer GroupOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT03786003 | ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007) | recruiting | N/A | 1,086 | Fudan UniversityOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05778708 | Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients | recruiting | N/A | 318 | The University of Hong KongOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05354596 | A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).(STRICTSTARLUNG) | recruiting | N/A | 138 | Rigshospitalet, DenmarkOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT04720339 | Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. | recruiting | N/A | 250 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT04451473 | Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery | recruiting | N/A | 350 | The Second Hospital of Shandong UniversityOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05494021 | China Lung Cancer Screening (CLUS) Study Version 3.0 | recruiting | N/A | 100,000 | Shanghai Chest HospitalOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT02354274 | Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine® | recruiting | N/A | 330 | Olfred HansenOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT04944563 | Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field | recruiting | N/A | 1,120 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 5, 2022 | clinicaltrials |
| NCT05033691 | A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases | recruiting | N/A | 162 | Hadassah Medical OrganizationOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Dec 19, 2024source: clinicaltrials